Recombinant human interferon-α1b inhibits SARS-CoV-2 better than interferon-α2b in vitro

Danrong Shi1, Keda Chen2, Xiangyun Lu1

  • 1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.

Virologica Sinica
|May 21, 2022
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos